FR2717802B1 - New aromatic compounds, process for their preparation and pharmaceutical compositions containing them. - Google Patents

New aromatic compounds, process for their preparation and pharmaceutical compositions containing them.

Info

Publication number
FR2717802B1
FR2717802B1 FR9403560A FR9403560A FR2717802B1 FR 2717802 B1 FR2717802 B1 FR 2717802B1 FR 9403560 A FR9403560 A FR 9403560A FR 9403560 A FR9403560 A FR 9403560A FR 2717802 B1 FR2717802 B1 FR 2717802B1
Authority
FR
France
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
aromatic compounds
new aromatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9403560A
Other languages
French (fr)
Other versions
FR2717802A1 (en
Inventor
Xavier Emonds-Alt
Vincenzo Proietto
Didier Van Broeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Priority to FR9403560A priority Critical patent/FR2717802B1/en
Priority to HU9503366A priority patent/HUT73226A/en
Priority to JP7525003A priority patent/JPH08511277A/en
Priority to AU21422/95A priority patent/AU2142295A/en
Priority to EP95914415A priority patent/EP0700382A1/en
Priority to PCT/FR1995/000369 priority patent/WO1995026335A1/en
Publication of FR2717802A1 publication Critical patent/FR2717802A1/en
Application granted granted Critical
Publication of FR2717802B1 publication Critical patent/FR2717802B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
FR9403560A 1994-03-25 1994-03-25 New aromatic compounds, process for their preparation and pharmaceutical compositions containing them. Expired - Fee Related FR2717802B1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR9403560A FR2717802B1 (en) 1994-03-25 1994-03-25 New aromatic compounds, process for their preparation and pharmaceutical compositions containing them.
HU9503366A HUT73226A (en) 1994-03-25 1995-03-24 With arylaliphatic and alkyl-groups n-substituted novel amides, method for their preparation and pharmaceutical compositions containing same
JP7525003A JPH08511277A (en) 1994-03-25 1995-03-24 Novel amides functionalized with n-arylaliphatic-n-alkyl, processes for their preparation and pharmaceutical compositions in which they are present
AU21422/95A AU2142295A (en) 1994-03-25 1995-03-24 Novel n-arylaliphatic-n-alkyl-functionalised amides, method for their prepation and pharmaceutical compositions containing same
EP95914415A EP0700382A1 (en) 1994-03-25 1995-03-24 Novel n-arylaliphatic-n-alkyl-functionalised amides, method for their prepation and pharmaceutical compositions containing same
PCT/FR1995/000369 WO1995026335A1 (en) 1994-03-25 1995-03-24 Novel n-arylaliphatic-n-alkyl-functionalised amides, method for their preparation and pharmaceutical compositions containing same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9403560A FR2717802B1 (en) 1994-03-25 1994-03-25 New aromatic compounds, process for their preparation and pharmaceutical compositions containing them.

Publications (2)

Publication Number Publication Date
FR2717802A1 FR2717802A1 (en) 1995-09-29
FR2717802B1 true FR2717802B1 (en) 1996-06-21

Family

ID=9461451

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9403560A Expired - Fee Related FR2717802B1 (en) 1994-03-25 1994-03-25 New aromatic compounds, process for their preparation and pharmaceutical compositions containing them.

Country Status (6)

Country Link
EP (1) EP0700382A1 (en)
JP (1) JPH08511277A (en)
AU (1) AU2142295A (en)
FR (1) FR2717802B1 (en)
HU (1) HUT73226A (en)
WO (1) WO1995026335A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413959B1 (en) 1995-04-14 2002-07-02 Boehringer Ingelheim Kg Method of treating depression with arylglycinamide derivatives
DE19519245C2 (en) * 1995-04-14 2003-04-30 Boehringer Ingelheim Kg Novel arylglycine amide derivatives, processes for their preparation and pharmaceutical compositions containing them
TW449590B (en) * 1995-04-14 2001-08-11 Boehringer Ingelheim Kg New arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds
US5696267A (en) * 1995-05-02 1997-12-09 Schering Corporation Substituted oximes, hydrazones and olefins as neurokinin antagonists
US5688960A (en) * 1995-05-02 1997-11-18 Schering Corporation Substituted oximes, hydrazones and olefins useful as neurokinin antagonists
US5654316A (en) * 1995-06-06 1997-08-05 Schering Corporation Piperidine derivatives as neurokinin antagonists
US5789422A (en) * 1996-10-28 1998-08-04 Schering Corporation Substituted arylalkylamines as neurokinin antagonists
FR2759585B1 (en) 1997-02-17 1999-06-11 Sanofi Sa PHARMACEUTICAL FORMULATIONS PRESENTED IN A DRY FORM FOR THE ORAL ADMINISTRATION OF A CYCLIC QUATERNARY AMMONIUM COMPOUND
FR2761901B1 (en) 1997-04-10 1999-05-14 Valeo METHOD FOR PRODUCING A FILTERING DEVICE AND FILTERING DEVICE IN PARTICULAR FOR AERATION AND / OR AIR CONDITIONING OF PREMISES OR VEHICLES
US6063926A (en) * 1998-11-18 2000-05-16 Schering Corporation Substituted oximes as neurokinin antagonists
CA2441235C (en) 2001-03-21 2011-05-24 Pharmacopeia, Inc. Aryl and biaryl compounds having mch modulatory activity
DE60235617D1 (en) 2001-04-12 2010-04-22 Pharmacopeia Llc ARLY AND DIARYL PIPERIDINE DERIVATIVES USE AS MCH HEMMER

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI97540C (en) * 1989-11-06 1997-01-10 Sanofi Sa Process for the preparation of therapeutically useful aromatically substituted piperidine and piperazine derivatives
IL99320A (en) * 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical compositions containing them
FR2676054B1 (en) * 1991-05-03 1993-09-03 Sanofi Elf NOVEL N-ALKYLENEPIPERIDINO COMPOUNDS AND THEIR ENANTIOMERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2688219B1 (en) * 1992-03-03 1994-07-08 Sanofi Elf AMATONIUM QUATERNARY SALTS OF AMINO AROMATIC COMPOUNDS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2696178B1 (en) * 1992-09-30 1994-12-30 Sanofi Elf Quaternary basic amides, process for their preparation and pharmaceutical compositions containing them.
GB9321557D0 (en) * 1992-11-03 1993-12-08 Zeneca Ltd Carboxamide derivatives
DE69405862T2 (en) * 1993-05-06 1998-01-15 Merrell Pharma Inc SUBSTITUTED PYRROLIDIN-3-ALKYL-PIPERIDINE USEFUL AS TACHYKININ ANTAGONISTS
GB9310713D0 (en) * 1993-05-24 1993-07-07 Zeneca Ltd Aryl substituted heterocycles

Also Published As

Publication number Publication date
AU2142295A (en) 1995-10-17
EP0700382A1 (en) 1996-03-13
WO1995026335A1 (en) 1995-10-05
HUT73226A (en) 1996-07-29
HU9503366D0 (en) 1996-02-28
FR2717802A1 (en) 1995-09-29
JPH08511277A (en) 1996-11-26

Similar Documents

Publication Publication Date Title
DZ2128A1 (en) New compounds, process for their preparation and pharmaceutical compositions containing them.
FR2718136B1 (en) Amino aromatic compounds, process for their preparation and pharmaceutical compositions containing them.
DZ1889A1 (en) New quinoline derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2300A1 (en) Substituted 6,5-heterobicyclic derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2299A1 (en) Substituted 6,6-heterobicyclic derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2634A1 (en) New pleuromutilin derivatives, process for their preparation and pharmaceutical compositions containing them.
CY2537B1 (en) Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
DZ1957A1 (en) New piperidine derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2890A1 (en) 4-Carboxamino-2-substituted-1,2,3,4-tetrahydroquinoline, process for their preparation and pharmaceutical compositions containing them.
DZ2891A1 (en) New substituted tetrahydroquinoline derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2197A1 (en) 6-Phenylpyridyl-2-amine derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2303A1 (en) New indazole derivatives process for their preparation and pharmaceutical compositions containing them.
DZ2395A1 (en) New compounds with a dibenzocycloheptene nucleus, process for their preparation and pharmaceutical compositions containing them.
DZ2889A1 (en) 4-Carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines, process for their preparation and pharmaceutical compositions containing them.
MA26659A1 (en) NOVEL BENZIMIDAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR THEIR PREPARATION.
DZ2227A1 (en) New indole derivatives, process for their preparation and pharmaceutical formulations containing them.
DZ2962A1 (en) New 3-azabicycloÄ3,1,0Ühexane derivatives, process for their preparation and compositions containing them.
DZ2045A1 (en) Therapeutic amides, process for their preparation and compositions containing them.
DZ2745A1 (en) Novel bicycloÄ2.2.1Üheptanes for their preparation and pharmaceutical compositions containing them.
DZ3042A1 (en) New isothiazole derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2217A1 (en) Substituted imidazole derivatives, process for their preparation and compositions containing them.
DZ3045A1 (en) Novel i-3-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2777A1 (en) New quinazolinamine derivatives process for their preparation and pharmaceutical compositions containing them.
DZ2751A1 (en) New calciolytic compounds process for their preparation and pharmaceutical compositions containing them.
DZ2944A1 (en) New azalides, process for their preparation and pharmaceutical compositions containing them.

Legal Events

Date Code Title Description
ST Notification of lapse